A 76-year-old man presented with biochemical recurrence (BCR) of prostate cancer with an increase in the prostate-specific antigen (PSA) serum value to 1.4 ng/mL (doubling time: approximately 6 months). This evidence concerns the gene KLK3 and prostate cancer.